Genomic and transcriptional heterogeneity-based precision in personalized treatment for breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Genomic and transcriptional heterogeneity-based precision in personalized treatment for breast cancer

Published:2019-09 Issue:5 Volume:16 Page:361-364
ISSN:1741-0541
Container-title:Personalized Medicine
language:en
Short-container-title:Personalized Medicine

Author:

Antoniou Persefoni¹²,Ziogas Demosthenes E¹³,Vlachioti Aikaterini¹⁴,Lykoudis Eustathios G⁵,Mitsis Michail²⁵,Roukos Dimitrios H¹²⁵⁶

Affiliation:

1. Centre for Biosystems & Genome Network Medicine, Ioannina University, Ioannina, Greece

2. Department of Surgery, Ioannina University Hospital, Ioannina, Greece

3. Department of Surgery, ‘G Hatzikosta’ General Hospital, Ioannina, Greece

4. Department of Gynecology, General Hospital, Preveza, Greece

5. Cancer Biobank Centre, Department of Medicine, University of Ioannina, Ioannina, Greece

6. Department of Systems Biology, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece

Publisher

Future Medicine Ltd

Subject

Pharmacology,Molecular Medicine,General Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/pme-2019-0036

Reference22 articles.

1. Network NCC. National Comprehensive Cancer Network (2019). www.nccn.org/

2. Dynamic genome and transcriptional network‐based biomarkers and drugs: precision in breast cancer therapy

3. Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

4. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive analysis of pyroptotic gene prognostic signatures associated with tumor immune microenvironment and genomic mutation in breast cancer;Frontiers in Immunology;2022-08-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3